Veradermics to present phase 3 hair loss trial results Monday

Where Will CRISPR Therapeutics Stock Be in 2030?

NASDAQ · Markets 48m ago

ServiceNow vs. Workday: Here's What Revenue Growth Trends Between These Software Companies Tell Investors

NASDAQ · Markets 57m ago

Russia stocks lower at close of trade; MOEX Russia Index unchanged

Investing.com · News 1h ago

Some Investors Are Questioning the AI Trade. Microsoft Is Bucking the Trend

NASDAQ · Markets 1h ago

Disc Medicine to present Phase 3 trial results for bitopertin

Investing.com · News 1h ago

Mink Brook asset management, 10% owner, rebalances $736,666 in DLH stock

Investing.com · News 1h ago

For Three Buffetts, a $150 Billion Puzzle Over Warren’s Riches

Bloomberg · Markets Video 1h ago

Is Citigroup Stock a Buy 13% Below Its 52-Week High?

NASDAQ · Markets 1h ago

Park Ohio Holdings CLO Vilsack sells $207,112 in common stock

Investing.com · News 1h ago

AI Agents Trading Stocks While You Sleep? Charles Schwab’s CEO Is Skeptical

Dow Jones · Markets 1h ago